Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chang Ik Choi

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Pharmacogenetics and Genomics|December 11, 2013
Strongly increased exposure of meloxicam in CYP2C9*3/*3 individualsHye-In Lee, Jung-Woo Bae, Chang-Ik Choi, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 17, 2012
Determination of tamsulosin in human plasma by liquid chromatography/tandem mass spectrometry and its application to a pharmacokinetic studyChang-Ik Choi, Hye-In Lee, Jung-Woo Bae, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 21, 2012
Effects of OCT2 c.602C > T genetic variant on the pharmacokinetics of lamivudineChang-Ik Choi, Jung-Woo Bae, Seul-Ki Keum, et al.
European Journal of Clinical Pharmacology|August 16, 2011
CYP2C9 3 and 13 alleles significantly affect the pharmacokinetics of irbesartan in healthy Korean subjectsChang-Ik Choi, Mi-Jeong Kim, Eun-Kyung Chung, et al.
Bioorganic Chemistry|November 11, 2017
Chemical characterization of cytotoxic indole acetic acid derivative from mulberry fruit (Morus alba L.) against human cervical cancerJae Sik Yu, Dahae Lee, Seoung Rak Lee, et al.
ACS Applied Materials & Interfaces|September 1, 2025
Atomic Layer Deposition of ZrO<sub>2</sub> Films at High Temperatures (>350 °C) Using a Modified Cyclopentadienyl Zr PrecursorJae Chan Park, Chang Ik Choi, Hongseok Jang, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 15, 2011
Effects of the SLCO1B1*15 allele on the pharmacokinetics of pitavastatinChang-Ik Choi, Yun-Jeong Lee, Hye-In Lee, et al.
Molecular Medicine Reports|March 22, 2019
Resveratrol is an arginase inhibitor contributing to vascular smooth muscle cell vasoconstriction via increasing cytosolic calciumChang Ik Choi, Bon Hyeock Koo, Dongeui Hong, et al.
Archives of Pharmacal Research|December 27, 2023
PBPK modeling to predict the pharmacokinetics of pantoprazole in different CYP2C19 genotypesChang-Keun Cho, Eunvin Ko, Ju Yeon Mo, et al.
Archives of Pharmacal Research|December 30, 2023
Physiologically based pharmacokinetic (PBPK) modeling of pitavastatin in relation to SLCO1B1 genetic polymorphismChang-Keun Cho, Ju Yeon Mo, Eunvin Ko, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Pharmacogenetics and Genomics|December 11, 2013
Strongly increased exposure of meloxicam in CYP2C9*3/*3 individualsHye-In Lee, Jung-Woo Bae, Chang-Ik Choi, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 17, 2012
Determination of tamsulosin in human plasma by liquid chromatography/tandem mass spectrometry and its application to a pharmacokinetic studyChang-Ik Choi, Hye-In Lee, Jung-Woo Bae, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 21, 2012
Effects of OCT2 c.602C > T genetic variant on the pharmacokinetics of lamivudineChang-Ik Choi, Jung-Woo Bae, Seul-Ki Keum, et al.
European Journal of Clinical Pharmacology|August 16, 2011
CYP2C9 3 and 13 alleles significantly affect the pharmacokinetics of irbesartan in healthy Korean subjectsChang-Ik Choi, Mi-Jeong Kim, Eun-Kyung Chung, et al.
Bioorganic Chemistry|November 11, 2017
Chemical characterization of cytotoxic indole acetic acid derivative from mulberry fruit (Morus alba L.) against human cervical cancerJae Sik Yu, Dahae Lee, Seoung Rak Lee, et al.
ACS Applied Materials & Interfaces|September 1, 2025
Atomic Layer Deposition of ZrO<sub>2</sub> Films at High Temperatures (>350 °C) Using a Modified Cyclopentadienyl Zr PrecursorJae Chan Park, Chang Ik Choi, Hongseok Jang, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 15, 2011
Effects of the SLCO1B1*15 allele on the pharmacokinetics of pitavastatinChang-Ik Choi, Yun-Jeong Lee, Hye-In Lee, et al.
Molecular Medicine Reports|March 22, 2019
Resveratrol is an arginase inhibitor contributing to vascular smooth muscle cell vasoconstriction via increasing cytosolic calciumChang Ik Choi, Bon Hyeock Koo, Dongeui Hong, et al.
Archives of Pharmacal Research|December 27, 2023
PBPK modeling to predict the pharmacokinetics of pantoprazole in different CYP2C19 genotypesChang-Keun Cho, Eunvin Ko, Ju Yeon Mo, et al.
Archives of Pharmacal Research|December 30, 2023
Physiologically based pharmacokinetic (PBPK) modeling of pitavastatin in relation to SLCO1B1 genetic polymorphismChang-Keun Cho, Ju Yeon Mo, Eunvin Ko, et al.
Pageof 7